What does HER2 status mean for Multiple Myeloma treatment
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
HER2 Status and Multiple Myeloma: Important Clarification
I appreciate this question because it highlights an important distinction in cancer care. HER2 status is NOT typically relevant for multiple myeloma treatment planning.
Here's why:
HER2 Testing in Different Cancers
HER2 (human epidermal growth factor receptor 2) is a protein that's important in specific cancers, particularly:
- Breast cancer - where HER2 testing is standard and guides treatment decisions
- Gastric (stomach) cancer - where HER2 status helps determine therapy options
- Some other solid tumors
According to NCCN Guidelines for breast cancer, HER2 testing determines whether patients benefit from HER2-targeted therapies like trastuzumab (Herceptin) or pertuzumab. However, multiple myeloma is a blood cancer with a completely different biology.
What Actually Matters for Myeloma Treatment
According to the NCCN Guidelines for Patients: Multiple Myeloma, the biomarkers that DO guide treatment decisions include:
- Chromosomal abnormalities (detected by FISH testing) - such as deletions of chromosome 17, translocations involving chromosome 14, or amplification of chromosome 1q21
- M protein type (IgG, IgA, IgM, kappa, or lambda)
- Free light chain levels
- Bone marrow involvement percentage
These findings help determine whether your myeloma is standard-risk or high-risk, which influences treatment intensity and approach.
Questions to Ask Your Myeloma Team
If you have multiple myeloma, consider asking:
- What is my specific cytogenetic risk profile? (This is what matters for myeloma)
- What is my M protein type and level?
- Have I had FISH testing to look for high-risk chromosomal changes?
- Based on these findings, what treatment approach do you recommend?
If you have a different cancer type (like breast cancer) AND myeloma, that would be unusual and would require specialized discussion with your care team about each cancer separately.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Multiple Myeloma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Multiple Myeloma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What is the life expectancy for multiple myeloma cancer
I understand this is one of the most important questions you might have. Let me share what the current medical evidence shows, while being clear about
What is the 5-year survival rate for multiple myeloma
I appreciate this important question, but I need to be transparent with you: the NCCN Guidelines for Patients materials I have access to don't include
What is the average survival rate for multiple myeloma by stage
I appreciate this important question. However, I need to be direct with you: the NCCN Guidelines for Patients that I have access to do not include spe